COMORBIDITY OF ROSACEA AND VARIOUS PATHOLOGICAL CONDITIONS AMONG THE POPULATION OF THE COUNTRIES OF THE WORLD, ACCOUNTING FOR TREATMENT AND PREVENTIVE MEASURES

  • Authors: Sadykova R.N.1, Plutnitsky A.N.1, Mingazova E.N.1,2,3
  • Affiliations:
    1. Biomedical University of Innovation and Continuing Education of the State Scientific Center of the Russian Federation A. I. Burnazyan Federal Medical Biophysical Center, 123098, Moscow, Russia
    2. N. A. Semashko National Research Institute of Public Health, 105064, Moscow, Russia
    3. Kazan State Medical University, 420012, Kazan, Russia
  • Issue: Vol 31 (2023): NO ()
  • Pages: 881-886
  • Section: Articles
  • URL: https://journal-nriph.ru/journal/article/view/2042
  • DOI: https://doi.org/10.32687/0869-866X-2023-31-s1-881-886
  • Cite item

Abstract


Currently, there is an urgent need for global research to develop a modern comprehensive study of rosacea, including its pathogenesis, risk factors, association of rosacea subtypes with concomitant diseases. The most relevant research studies the role of immunity and microorganisms in the pathogenesis of rosacea. To elucidate the features of the comorbidity of rosacea and somatic diseases, studies in various populations with detailed clinical data and a longer follow up period are important. At the same time, it is important to understand the relationship between the severity and severity of various clinical symptoms of rosacea, the mechanisms that regulate the progression of the process, the combination of rosacea subtypes and the course of the disease in association with other forms of pathological disorders.

About the authors

R. N. Sadykova

Biomedical University of Innovation and Continuing Education of the State Scientific Center of the Russian Federation A. I. Burnazyan Federal Medical Biophysical Center, 123098, Moscow, Russia

A. N. Plutnitsky

Biomedical University of Innovation and Continuing Education of the State Scientific Center of the Russian Federation A. I. Burnazyan Federal Medical Biophysical Center, 123098, Moscow, Russia

E. N. Mingazova

Biomedical University of Innovation and Continuing Education of the State Scientific Center of the Russian Federation A. I. Burnazyan Federal Medical Biophysical Center, 123098, Moscow, Russia; N. A. Semashko National Research Institute of Public Health, 105064, Moscow, Russia; Kazan State Medical University, 420012, Kazan, Russia

References

  1. Awosika O., Oussedik E. Genetic predisposition to rosacea // Dermatol. Clin. 2018. Vol. 36, N 2. P. 87—92. doi: 10.1016/j.det.2017.11.002
  2. Aponte J. L., Chiano M. N., Yerges-Armstrong L. M. et al. Assessment of rosacea symptom severity by genome-wide association study and expression analysis highlights immuno-inflammatory and skin pigmentation genes // Hum. Mol. Genet. 2018. Vol. 27, N 15. P. 2762—2772. doi: 10.1093/hmg/ddy184
  3. Liu L., Chen Y., Chen J. et al. Association between frontal fibrosing Alopecia and Rosacea: results from clinical observational studies and gene expression profiles // Front. Immunol. 2022. Vol. 13. P. 985081. doi: 10.3389/fimmu.2022.985081
  4. Oliveira C. M.M., Almeida L. M.C., Bonamigo R. R. et al. Consensus on the therapeutic management of rosacea — Brazilian Society of Dermatology // An. Bras. Dermatol. 2020. Vol. 9, N 5, Suppl 1. P. 53—69. doi: 10.1016/j.abd.2020.08.001
  5. Zhang J., Yan Y., Jiang P. et al. Association between rosacea and cardiovascular disease: A systematic review and meta-analysis // J. Cosmet. Dermatol. 2021. Vol. 20, N 9. P. 2715—2722. doi: 10.1111/jocd.13885
  6. Chang H. C., Huang Y. C., Lien Y. J., Chang Y. S. Association of rosacea with depression and anxiety: A systematic review and meta-analysis // J. Affect. Disord. 2022. Vol. 299. P. 239—245. doi: 10.1016/j.jad.2021.12.008
  7. Incel Uysal P., Akdogan N., Hayran Y. et al. Rosacea associated with increased risk of generalized anxiety disorder: a case-control study of prevalence and risk of anxiety in patients with rosacea // An. Bras. Dermatol. 2019. Vol. 94, N 6. P. 704—709. doi: 10.1016/j.abd.2019.03.002
  8. Tsai T. Y., Chiang Y. Y., Huang Y. C. Cardiovascular risk and comorbidities in patients with rosacea: a systematic review and meta-analysis // Acta Derm. Venereol. 2020. Vol. 100, N 17. P. adv00300. doi: 10.2340/00015555-3668
  9. Cho S. I., Lee H., Cho S. Risk of Skin cancer and actinic keratosis in patients with rosacea: a nationwide population-based cohort study // Acta Derm. Venereol. 2022. Vol. 102. P. adv00803. doi: 10.2340/actadv.v102.2563
  10. Wu Y., Li X., Chen S. et al. Inflammatory bowel disease and rosacea: a two-sample mendelian randomization study // Dermatol. Ther. 2023. Vol. 2023. doi: 10.1155/2023/1353823
  11. Li S., Cho E., Drucker A. M. et al. Obesity and risk for incident rosacea in US women // J. Am. Acad. Dermatol. 2017. Vol. 77, N 6. P. 1083—1087.e5. doi: 10.1016/j.jaad.2017.08.032
  12. Wienholtz N. K.F., Christensen C. E., Zhang D. G. et al. Clinical characteristics of combined rosacea and migraine // Front. Med. (Lausanne). 2022. Vol. 9. P. 1026447. doi: 10.3389/fmed.2022.1026447
  13. Akin Belli A., Alatas E. T., Kara Polat A., Akbaba G. Assessment of thyroid disorders in patients with rosacea: a large case-control study // An. Bras. Dermatol. 2021. Vol. 96, N 5. P. 539—543. doi: 10.1016/j.abd.2021.02.004
  14. Chung B. Y., Kim H. O., Park C. W. et al. Relationships of serum homocysteine, vitamin B12, and folic acid levels with papulopustular rosacea severity: a case-control study // Biomed. Res. Int. 2022. P. 5479626. doi: 10.1155/2022/5479626
  15. Forton F. M. N. The pathogenic role of demodex mites in rosacea: a potential therapeutic target already in erythematotelangiectatic rosacea // Dermatol. Ther. (Heidelb). 2020. Vol. 10, N 6. P. 1229—1253. doi: 10.1007/s13555-020-00458-9
  16. Forton F. M. N. Rosacea, an infectious disease: why rosacea with papulopustules should be considered a demodicosis. A narrative review // J. Eur. Acad. Dermatol. Venereol. 2022. Vol. 36, N 7. P. 987—1002. doi: 10.1111/jdv.18049
  17. Nobeyama Y., Aihara Y., Asahina A. Characteristics of rosacea and similar diseases in patients wearing face masks // Skin Appendage Disord. 2022. Vol. 8, N 6. P. 462—468. doi: 10.1159/000525024
  18. Dall'Oglio F., Fusto C., Micali G. Intrafamilial transmission of rosacea spanning six generations: a retrospective observational study // J. Clin. Aesthet. Dermatol. 2022. Vol. 15, N 2. P. 35—39.
  19. Buddenkotte J., Steinhoff M. Recent advances in understanding and managing rosacea // F1000Res. 2018. Vol. 7. P. F1000 Faculty Rev-1885. doi: 10.12688/f1000research.16537.1
  20. Marchitto M. C., Chien A. L. Rosacea and associated comorbidities: a Google search trends analysis // J. Clin. Aesthet. Dermatol. 2020. Vol. 13, N 7. P. 36—40.
  21. Yang F., Zhang Q., Song D. et al. A Cross-sectional study on the relationship between rosacea severity and quality of life or psychological state // Clin. Cosmet. Investig. Dermatol. 2022. Vol. 15. P. 2807—2816. doi: 10.2147/CCID.S390921
  22. Kang C. N., Shah M., Tan J. Rosacea: an update in diagnosis, classification and management // Skin Therapy Lett. 2021. Vol. 26, N 4. P. 1—8.
  23. Nowicka D., Chilicka K., Dzieńdziora-Urbińska I., Szyguła R. Skincare in rosacea from the cosmetologist's perspective: a narrative review // J. Clin. Med. 2022. Vol. 12, N 1. P. 115. doi: 10.3390/jcm12010115
  24. Hu X. M., Li Z. X., Zhang D. Y. et al. Current research and clinical trends in rosacea pathogenesis // Heliyon. 2022. Vol. 8, N 10. P. e10874. doi: 10.1016/j.heliyon.2022.e10874
  25. Zierl S., Guertler A., Hildebrand J. A. et al. A comprehensive epidemiological study of rosacea in Germany // Eur. J. Dermatol. 2021. Vol. 31, N 6. P. 744—751. doi: 10.1684/ejd.2021.4165
  26. van Zuuren E. J., Arents B. W.M., van der Linden M. M.D. et al. Rosacea: new concepts in classification and treatment // Am. J. Clin. Dermatol. 2021. Vol. 22, N 4. P. 457—465. doi: 10.1007/s40257-021-00595-7
  27. Miyachi Y., Yamasaki K., Fujita T., Fujii C. Metronidazole gel (0.75%) in Japanese patients with rosacea: a randomized, vehicle-controlled, phase 3 study // J. Dermatol. 2022. Vol. 49, N 3. P. 330—340. doi: 10.1111/1346-8138.16254
  28. Del Rosso J. Q., York J. P., Bhatia N. Effective treatment of inflammatory lesions of rosacea with subantibiotic dose doxycycline irrespective of patient weight or baseline lesion count severity // J. Clin. Aesthet. Dermatol. 2022. Vol. 15, N 11. P. 69—74.
  29. van Zuuren E. J., Fedorowicz Z., Tan J. et al. Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments // Br. J. Dermatol. 2019. Vol. 181, N 1. P. 65—79. doi: 10.1111/bjd.17590
  30. Sarkar R., Podder I., Jagadeesan S. Rosacea in skin of color: A comprehensive review // Indian J. Dermatol. Venereol. Leprol. 2020. Vol. 86, N 6. P. 611—621. doi: 10.4103/ijdvl.IJDVL_769_19
  31. Maliyar K., Abdulla S. J. Dermatology: how to manage rosacea in skin of colour // Drugs Context. 2022. Vol. 11. P. 2021-11-1. doi: 10.7573/dic.2021-11

Statistics

Views

Abstract - 28

PDF (Russian) - 10

Cited-By


PlumX

Dimensions


Copyright (c) 1970 АО "Шико"

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Mailing Address

Address: 105064, Vorontsovo Pole, 12, Moscow

Email: ttcheglova@gmail.com

Phone: +7 903 671-67-12

Principal Contact

Tatyana Sheglova
Head of the editorial office
FSSBI «N.A. Semashko National Research Institute of Public Health»

105064, Vorontsovo Pole st., 12, Moscow


Phone: +7 903 671-67-12
Email: redactor@journal-nriph.ru

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies